Type 2 diabetes: epidemiology and treatment, pathophysiology, new therapeutics, and the evolving role of the pharmacist.

Journal of the American Pharmacists Association : JAPhA

Volumn 49 Suppl 1, Issue , 2009, Pages

  Campbell, R Keith ^a   Neumiller, Joshua J ^a   White, John ^a   Sisson, Evan ^a   Kuhn, Catherine ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; DIPEPTIDYL PEPTIDASE IV; DIPEPTIDYL PEPTIDASE IV INHIBITOR; DPP4 PROTEIN, HUMAN; GLUCAGON LIKE PEPTIDE RECEPTOR; GLUCAGON RECEPTOR; GLUCAGON-LIKE PEPTIDE RECEPTOR; INCRETIN;

ATTITUDE TO HEALTH; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; EDITORIAL; GLUCOSE BLOOD LEVEL; HEALTH PERSONNEL ATTITUDE; HUMAN; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PATIENT EDUCATION; PHARMACIST; PROFESSIONAL STANDARD; TREATMENT OUTCOME;

ANTIGENS, CD26; ATTITUDE OF HEALTH PERSONNEL; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPOGLYCEMIC AGENTS; INCRETINS; PATIENT EDUCATION AS TOPIC; PHARMACISTS; PROFESSIONAL ROLE; RECEPTORS, GLUCAGON; TREATMENT OUTCOME;

EID: 70350495816     PISSN: None     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2009.09537     Document Type: Editorial

References (0)